1. Home
  2. DNLI vs WKC Comparison

DNLI vs WKC Comparison

Compare DNLI & WKC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNLI
  • WKC
  • Stock Information
  • Founded
  • DNLI 2013
  • WKC 1984
  • Country
  • DNLI United States
  • WKC United States
  • Employees
  • DNLI N/A
  • WKC N/A
  • Industry
  • DNLI Biotechnology: Biological Products (No Diagnostic Substances)
  • WKC Oil Refining/Marketing
  • Sector
  • DNLI Health Care
  • WKC Energy
  • Exchange
  • DNLI Nasdaq
  • WKC Nasdaq
  • Market Cap
  • DNLI 1.9B
  • WKC 1.5B
  • IPO Year
  • DNLI 2017
  • WKC N/A
  • Fundamental
  • Price
  • DNLI $13.21
  • WKC $27.35
  • Analyst Decision
  • DNLI Strong Buy
  • WKC Sell
  • Analyst Count
  • DNLI 15
  • WKC 4
  • Target Price
  • DNLI $33.85
  • WKC $29.00
  • AVG Volume (30 Days)
  • DNLI 1.3M
  • WKC 623.8K
  • Earning Date
  • DNLI 05-06-2025
  • WKC 07-24-2025
  • Dividend Yield
  • DNLI N/A
  • WKC 2.48%
  • EPS Growth
  • DNLI N/A
  • WKC N/A
  • EPS
  • DNLI N/A
  • WKC 0.32
  • Revenue
  • DNLI N/A
  • WKC $40,669,100,000.00
  • Revenue This Year
  • DNLI N/A
  • WKC N/A
  • Revenue Next Year
  • DNLI $256.73
  • WKC $5.20
  • P/E Ratio
  • DNLI N/A
  • WKC $84.38
  • Revenue Growth
  • DNLI N/A
  • WKC N/A
  • 52 Week Low
  • DNLI $10.57
  • WKC $22.71
  • 52 Week High
  • DNLI $33.33
  • WKC $31.71
  • Technical
  • Relative Strength Index (RSI)
  • DNLI 44.46
  • WKC 54.48
  • Support Level
  • DNLI $12.86
  • WKC $26.68
  • Resistance Level
  • DNLI $13.77
  • WKC $28.00
  • Average True Range (ATR)
  • DNLI 0.72
  • WKC 0.47
  • MACD
  • DNLI -0.08
  • WKC -0.02
  • Stochastic Oscillator
  • DNLI 32.29
  • WKC 44.32

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

About WKC World Kinect Corporation

World Kinect Corp is an energy management company involved in providing supply fulfillment, energy procurement advisory services, and transaction and payment management solutions to commercial and industrial customers. It sells and delivers liquid fuels, natural gas, electricity, renewable energy, and other sustainability solutions. The company operates in three reportable segments consisting of aviation, land, and marine. The company earns the majority of its revenue from the Aviation segment.

Share on Social Networks: